Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]

Price DB, Henley W, Cançado JED, et al. Int J Chron Obstruct Pulmon Dis. 2022;17:355–370 On page 356, last paragraph of the Introduction section, the paragraph should be corrected from “ …Collectively, there is a requirement for a real- world study comparing the use of extr...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2022-03-01
Serie:	International Journal of COPD
Soggetti:	inhaled corticosteroids pneumonia copd extrafine beclomethasone fluticasone
Accesso online:	https://www.dovepress.com/corrigendum-interclass-difference-in-pneumonia-risk-in-copd-patients-i-peer-reviewed-fulltext-article-COPD
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!